Sign in

Filings

Finds words inside filing documents. Searching Amneal Pharmaceuticals, Inc.'s filings · 41 documents indexed.

15 documents · 68 matches

  1. AMRX Amneal Pharmaceuticals, Inc. 10-Q 2026-05-07

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs. Certain branded pharmaceutical products and their APIs are subject to tariffs of up to 100%, with the potential for tariff
    8 matches in this document

  2. AMRX Amneal Pharmaceuticals, Inc. 10-K 2026-02-27

    Item 1A. Risk Factors

    tariff actions, and while there are currently no reciprocal tariffs on pharmaceutical products imported into the U.S., this can change
    14 matches in this document

  3. AMRX Amneal Pharmaceuticals, Inc. 10-Q 2026-11-09

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff measures, as discussed in Part II., Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    9 matches in this document

  4. AMRX Amneal Pharmaceuticals, Inc. 10-Q 2026-08-06

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff measures, as discussed in Part II., Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    8 matches in this document

  5. AMRX Amneal Pharmaceuticals, Inc. 10-Q 2025-11-06

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff actions, and while there are currently no reciprocal tariffs on pharmaceutical products imported into the U.S., this can change
    7 matches in this document

  6. AMRX Amneal Pharmaceuticals, Inc. 10-Q 2025-08-07

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff actions, and while there are currently no reciprocal tariffs on pharmaceutical products imported into the U.S., this can change
    7 matches in this document

  7. AMRX Amneal Pharmaceuticals, Inc. 10-Q 2025-05-07

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff actions, and while there are currently no reciprocal tariffs on pharmaceutical products imported into the U.S., this can change
    7 matches in this document

  8. AMRX Amneal Pharmaceuticals, Inc. 8-K 2026-11-03

    tariffs may adversely affect our business, results of operations and financial condition; a U.S. government shutdown could adversely impact our regulatory
    1 match in this document

  9. AMRX Amneal Pharmaceuticals, Inc. 8-K 2026-08-10

    tariffs may adversely affect our business, results of operations and financial condition; a U.S. government shutdown could adversely impact our regulatory
    1 match in this document

  10. AMRX Amneal Pharmaceuticals, Inc. 8-K 2026-07-30

    tariffs may adversely affect our business, results of operations and financial condition; a U.S. government shutdown could adversely impact our regulatory
    1 match in this document

  11. AMRX Amneal Pharmaceuticals, Inc. 8-K 2026-05-07

    tariffs may adversely affect our business, results of operations and financial condition; a U.S. government shutdown could adversely impact our regulatory
    1 match in this document

  12. AMRX Amneal Pharmaceuticals, Inc. 8-K 2026-02-27

    tariffs may adversely affect our business, results of operations and financial condition; a U.S. government shutdown could adversely impact our regulatory
    1 match in this document

  13. AMRX Amneal Pharmaceuticals, Inc. 8-K 2025-10-30

    tariffs may adversely affect our business, results of operations and financial condition; legal, regulatory and legislative efforts by our brand
    1 match in this document

  14. AMRX Amneal Pharmaceuticals, Inc. 8-K 2025-08-05

    tariffs may adversely affect our business, results of operations and financial condition; legal, regulatory and legislative efforts by our brand
    1 match in this document

  15. AMRX Amneal Pharmaceuticals, Inc. 8-K 2025-07-21

    tariffs may adversely affect our business, results of operations and financial condition; legal, regulatory and legislative efforts by our brand
    1 match in this document

Page 1 of 1 · 15 documents